Clinical Trial Update: Dapagliflozin in Reducing Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction [NA]

View source ↗

Summary

This clinical trial is investigating whether dapagliflozin can reduce epicardial adipose tissue in heart failure with preserved ejection fraction; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Aswan University | Conditions: Heart Failure with Preserved Ejection Fraction | NA | Status: NOT_YET_RECRUITING